Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-21
1996-12-10
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514210, 514212, 514422, 514861, 514863, A61K 31395, A61K 3155, A61K 31445, A61K 3140
Patent
active
055831435
ABSTRACT:
Methods and pharmaceutical compositions for use in inhibiting calmodulin activity in a patient are disclosed. 2,3-diaryl-1-benzopyrans and their pharmaceutically acceptable salts are formulated into medicaments, including oral and topical medicaments, which are administered to a patient in need of treatment of a non-estrogen dependent condition.
REFERENCES:
patent: 3313853 (1967-04-01), Lednicer
patent: 4742066 (1988-05-01), Deckner et al.
patent: 4851433 (1989-07-01), Kraus
patent: 4885309 (1989-12-01), Welton
patent: 5248777 (1993-09-01), Chandraratna
patent: 5254568 (1993-10-01), Kapil et al.
patent: 5446061 (1995-08-01), Bryant et al.
Mac Neil et al., British Journal of Dermatology 128: 143-150, 1993.
Wiseman, TiPS 15: 83-89, 1994.
Saeed et al., J. Med. Chem. 33: 3210-3216, 1990.
Sharma et al, J. Med. Chem. 33: 3216-3222, 1990.
Sharma et al., J. Med. Chem. 33: 3222-3229, 1990.
Labroo Virender M.
Piggott James R.
Jordan Kimberly
Leith Debra K.
Parker Gary E.
Sawislak Deborah A.
ZymoGenetics Inc.
LandOfFree
Methods for inhibiting calmodulin activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibiting calmodulin activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting calmodulin activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-424455